At least two retrospective observational studies now suggest that tirzepatide safely reduces weight, A1c, and insulin requirements in type 1 diabetes, with randomized control trial data to come.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/real-world-data-show-tirzepatide-benefit-type-1-diabetes-2025a1000o2n?src=rss
Author :
Publish date : 2025-09-11 12:38:00
Copyright for syndicated content belongs to the linked Source.
